Into clinical practice:
Pneumonia
HELD 6 APRIL 2022
View the recorded content from this online conference.
This conference is RCPath CPD accredited.
Programme
SESSION ONE: Epidemiology and Guidelines
Chair: Professor Philip Howard OBE, AMR Regional Antimicrobial Stewardship Lead, NHS England & NHS Improvement - North-East & Yorkshire, UK and immediate Past President, BSAC
-
-
INHALE update - incidence and prevalence
Professor David Livermore, Professor of Medical Microbiology, University of East Anglia - View Bio
-
Impact of antimicrobial prescribing during the COVID-pandemic on MDRO colonisation and the gut microbiome
Dr Jane Freeman, Associate Professor / Clinical Scientist, University of Leeds / Leeds Teaching Hospitals - View Bio
-
Q&A
SESSION TWO: The Patient and the pathway
Chair: Ms Sally Tipping, Specialist Antimicrobial Pharmacist, Royal Devon & Exeter Hospital
-
-
Community-acquired pneumonia in 2022; an update on recent clinical research
Dr Stephen Aston, Senior Clinical Lecturer and Consultant in Infectious Diseases, University of Liverpool and Liverpool University Hospitals NHS Trust - View Bio
-
Diagnostic and treatment challenges in HAP and VAP
Dr Tom Hellyer, Senior Clinical Fellow and Honorary Consultant Intensive Care Medicine, Newcastle University - View Bio
-
Pneumonia- a broken diagnosis and the need for a different paradigm
Professor Matthew Inada-Kim, Consultant Acute Physician National Clinical Director – Infection management, AMR, Deterioration National Specialty advisor- Sepsis National Clinical Lead- COVID oximetry/virtual wards, Hampshire Hospitals NHS Foundation Trust NHS England and NHS Improvement - View Bio
-
Q&A
SESSION THREE: PERSPECTIVES ON THE CLINICAL USE OF ANTIBIOTICS FOR DIFFICULT TO TREAT PATHOGENS IN PATIENTS WITH CYSTIC FIBROSIS (CF)
Supported by: Menarini
-
-
Respiratory
Dr Jacqueline C. Rendall
-
Microbiology
Professor John E. Moore
-
Q&A
SESSION FOUR: SUPPORTED SESSION
Supported by: Pfizer
-
-
Severe Nosocomial Pneumonia, New Aspects after Guidelines
Professor Antoni Torres, Department of Pulmonology, Hospital Clinic, University of Barcelona, Spain
SESSION FIVE: COVID-19
Chair: Professor Philip Howard OBE, AMR Regional Antimicrobial Stewardship Lead, NHS England & NHS Improvement - North-East & Yorkshire, UK and immediate Past President, BSAC
-
-
Antifungal stewardship and respiratory fungal disease
Dr Darius Armstrong-James, Reader in Infectious Diseases and Medical Mycology, Faculty of Medicine, Department of Infectious Disease - View Bio
-
Procalcitonin: Evaluation of Antibiotic use in COVID-19 Hospitalised patients
Professor Enitan Carrol, Professor of Paediatric Infection, University of Liverpool - View Bio
-
Results of the CATALYST trial in hospitalised patients with COVID-19 pneumonia
Dr Benjamin Fisher, Senior Clinical Lecturer, University of Birmingham - View Bio
-
Q&A
SESSION SIX: SUPPORTED SESSION
Supported by: Shionogi
-
-
Difficult to treat infections in critical care: a complex case study
Mr Stephen Hughes, Chelsea and Westminster Hospital NHS Foundation Trust, Consultant Antimicrobial Pharmacist
SESSION SEVEN: Paediatrics
Chair: Dr Sanjay Patel, Consultant in Paediatric Infectious Diseases and Immunology, Southampton Children’s Hospital
-
-
Challenges of managing pneumonia in the paediatric patient - an area for antimicrobial stewardship
Dr Julia Bielicki Consultant in Paediatric Infectious Diseases, Lead Physician Infection Prevention and Control University of Basel Children’s Hospital - View Bio
-
Paediatric Pneumonia - More research required
Dr Malcolm Brodlie, Clinical Senior Lecturer/Honorary Consultant in Paediatric Respiratory Medicine, Newcastle University/Great North Children’s Hospital - View Bio
-
Q&A
SESSION EIGHT: A vision for the future
Chair: Professor Tony Whitehouse, Consultant Critical Care & Anaesthesia Honorary Professor, University of Birmingham
-
-
What are the main drivers for change?
Professor Mervyn Singer, Professor of Intensive Care Medicine at University College London, past Chair of the International Sepsis Forum - View Bio
-
What are the main drivers for change?
Dr Ron Daniels BEM, Executive Director, UK Sepsis Trust - View Bio
-
Panel discussion
-
Closing remarks
Professor Philip Howard OBE, AMR Regional Antimicrobial Stewardship Lead, NHS England & NHS Improvement - North-East & Yorkshire, UK and immediate Past President, BSAC - View Bio
Having trouble finding what you're after?
© 2023, British Society for Antimicrobial Chemotherapy. All Rights Reserved.
Registered Charity
